Phreesia, Inc. (NYSE:PHR) SVP Sells $106,761.27 in Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 4,499 shares of Phreesia stock in a transaction on Wednesday, April 16th. The shares were sold at an average price of $23.73, for a total transaction of $106,761.27. Following the sale, the senior vice president now directly owns 217,239 shares of the company’s stock, valued at $5,155,081.47. This trade represents a 2.03 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

David Linetsky also recently made the following trade(s):

• On Tuesday, April 8th, David Linetsky sold 3,944 shares of Phreesia stock. The stock was sold at an average price of $23.85, for a total value of $94,064.40.
• On Tuesday, March 18th, David Linetsky sold 39 shares of Phreesia stock. The shares were sold at an average price of $26.95, for a total value of $1,051.05.
• On Thursday, February 13th, David Linetsky sold 11,616 shares of Phreesia stock. The stock was sold at an average price of $29.70, for a total value of $344,995.20.
• On Friday, February 7th, David Linetsky sold 300 shares of Phreesia stock. The shares were sold at an average price of $29.52, for a total value of $8,856.00.
• On Wednesday, February 5th, David Linetsky sold 720 shares of Phreesia stock. The shares were sold at an average price of $29.50, for a total transaction of $21,240.00.
• On Wednesday, January 29th, David Linetsky sold 500 shares of Phreesia stock. The stock was sold at an average price of $29.68, for a total transaction of $14,840.00.
• On Monday, January 27th, David Linetsky sold 11,685 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total transaction of $321,103.80.

Phreesia Price Performance

NYSE:PHR opened at $23.92 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. Phreesia, Inc. has a one year low of $17.07 and a one year high of $30.53. The company has a fifty day moving average price of $26.16 and a 200 day moving average price of $24.28. The stock has a market cap of $1.41 billion, a P/E ratio of -16.27 and a beta of 0.82.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Johnson Financial Group Inc. grew its position in Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock worth $28,000 after buying an additional 896 shares in the last quarter. R Squared Ltd acquired a new stake in shares of Phreesia during the 4th quarter worth approximately $30,000. BankPlus Trust Department acquired a new stake in shares of Phreesia during the 4th quarter worth approximately $34,000. Quarry LP raised its stake in shares of Phreesia by 210.9% in the fourth quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after purchasing an additional 1,923 shares in the last quarter. Finally, Venturi Wealth Management LLC bought a new position in Phreesia in the fourth quarter worth $76,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

Analyst Ratings Changes

PHR has been the topic of several analyst reports. DA Davidson lowered their target price on shares of Phreesia from $36.00 to $34.00 and set a “buy” rating on the stock in a research report on Monday. KeyCorp lowered their price objective on Phreesia from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Wednesday. Needham & Company LLC restated a “buy” rating and issued a $29.00 target price on shares of Phreesia in a report on Thursday, March 13th. Citigroup increased their price target on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Finally, Piper Sandler reissued an “overweight” rating and issued a $33.00 price target (up previously from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $31.33.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.